Article info
Original research
What constitutes a reasonable compensation for non-commercial oocyte donors: an analogy with living organ donation and medical research participation
- Correspondence to Ma Emy Kool; e.m.kool-3{at}umcutrecht.nl
Citation
What constitutes a reasonable compensation for non-commercial oocyte donors: an analogy with living organ donation and medical research participation
Publication history
- Received March 25, 2019
- Revised July 2, 2019
- Accepted July 16, 2019
- First published August 2, 2019.
Online issue publication
October 27, 2019
Article Versions
- Previous version (25 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Social egg freezing and donation: waste not, want not
- The need for donor consent in mitochondrial replacement
- Reproductive outsourcing: an empirical ethics account of cross-border reproductive care in Canada
- The stem cell debate continues: the buying and selling of eggs for research
- Narratives of neoliberalism: ‘clinical labour’ in context
- Join the Lone Kidney Club: incentivising live organ donation
- Development of hypertensive complications in oocyte donation pregnancy: protocol for a systematic review and individual participant data meta-analysis (DONOR IPD)
- Preventing transmission of maternally inherited mitochondrial DNA diseases
- Who is willing to take the risk? Assessing the readiness for living liver donation in the general German population
- Mitochondrial replacement techniques for treating infertility